Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer’s disease (Q57675765)

7

Kaj Blennow

0 references

Lennart Minthon

6

Lennart Minthon

0 references

Oskar Hansson

8

Oskar Hansson

0 references

Ulf Andreasson

2

Ulf Andreasson

0 references

Jonny Daborg

1

Jonny Daborg

0 references

Ronald Lautner

4

Ronald Lautner

0 references

Eric Hanse

5

Eric Hanse

0 references

author name string

Marcela Pekna

Journal of Neural Transmission

3

0 references

publication date

10 April 2012

0 references

published in

0 references

volume

119

0 references

page(s)

789-797

0 references

issue

7

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s00702-012-0797-8

0 references

cites work

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

Activation of complement and contact system in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

The significance of the complement system for the pathogenesis of age-related macular degeneration - current evidence and translation into clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

Enhanced synaptic connectivity and epilepsy in C1q knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

BIOLOGICAL ACTIVITIES OF C1 INHIBITOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

The role of complement and activated microglia in the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

Distribution pattern and functional state of complement proteins and alpha 1-antichymotrypsin in cerebral beta/A4 deposits in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

Complement protein isoforms in CSF as possible biomarkers for neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

Synthetic Alzheimer amyloid beta/A4 peptides enhance production of complement C3 component by cultured microglial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

APP processing and synaptic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

Visual impairment in Alzheimer's disease: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

The role of the classical complement cascade in synapse loss during development and glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

21 January 2018

The complement system

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

Genome-wide analysis of genetic loci associated with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

Decreased levels of C1q in cerebrospinal fluid of living Alzheimer patients correlate with disease state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

The classical complement cascade mediates CNS synapse elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

Complement regulators C1 inhibitor and CD59 do not significantly inhibit complement activation in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

Up-regulated production and activation of the complement system in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0797-8

Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22488444

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22488444